Nimesulide provides relief from primary dysmenorrhoea in adolescents & osteoarthritis. It’s a anti-inflammatory, non-steroidal drug. Nimusilide provides treatment for acute pain. But nimesulide has been drawn aside from the market because of its hepatic effects (risk of hepatatoxicity) on patients. In India this banned compound is still available easily. Because of the adverse reactions European countries & Israel has withdrawn nimesulide from market.
U.S government researchers find that an epilepsy drug that is being tested to treat addiction also helped to shed weight in obese rats.
The researchers said that their findings not only helped to treat drug addicts, but it also showed promising results for an easy treatment for obesity.
After 40 days of the drug injections (known as Vigabatrin or GVG), even those rats that were bred to be obese seemed to lose almost 19 percent of their weight and normal rats seemed to lose 12 to 20 percent weight.
